Hackensack Meridian Health is now enrolling individuals in the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 COVID-19 vaccine trial. The Phase 3 international, randomized, double-blind, placebo-controlled ENSEMBLE 2 trial run by Johnson and Johnson is designed to evaluate the safety and efficacy of a two-dose regimen of Janssen’s investigational COVID-19 vaccine candidate versus […]